Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

The latest price target for CME Group (NASDAQ:CME) was reported by Oppenheimer on June 4, 2025. The analyst firm set a price target for $300.00 expecting CME to rise to within 12 months (a ...

An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Group. The following ... some analysts extend their insights by offering predictions for key metrics ...

Currently, the analyst consensus on CME Group is a Moderate Buy with an average price target of $258.07, implying a -2.1% downside from current levels. In a report released today, Barclays also ...

Comparing current and prior targets offers insights into analysts' evolving expectations. To gain a panoramic view of CME Group's market performance, explore these analyst evaluations alongside ...

CME Group (CME) Barclays analyst Benjamin Budish maintained a Hold rating on CME Group today and set a price target of $257.00. The company’s shares closed last Friday at $229.20. According to ...

CME Group's strong performance and market-agnostic revenues support its resilience. Find out why CME stock is a Hold.

Strengths highlight CME Group Inc's robust financial performance and market leadership. Opportunities emphasize the company's potential for global expansion and product innovation. Weaknesses and ...

Initiate Strong Buy on CME Group with $332.96 PT ... We reiterate our Strong Buy with a $332.96 price target. Analyst’s Disclosure:I/we have no stock, option or similar derivative position ...

Lee is a Data Analyst for Saracens (which is sponsored by CME Group), and his job is to gather, analyze and ultimately develop practical, understandable insights and applications his coaches and ...

While the CME Group's launch of XRP futures has the market buzzing about a potential surge in the XRP price, another altcoin, FloppyPepe (FPPE), is quietly generating even more excitement among ...

Strengths highlight CME Group's robust market position and innovative product offerings. Weaknesses underscore the challenges in technology advancements and regulatory compliance. Opportunities ...